p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells (original) (raw)

• Jinek, M. et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337, 816–822 (2012).
  Article PubMed CAS PubMed Central Google Scholar
• Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819–823 (2013).
  Article PubMed PubMed Central CAS Google Scholar
• Mali, P. et al. RNA-guided human genome engineering via Cas9. Science 339, 823–826 (2013).
  Article PubMed PubMed Central CAS Google Scholar
• Hsu, P. D. et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat. Biotechnol. 31, 827–832 (2013).
  Article PubMed PubMed Central CAS Google Scholar
• He, X. et al. Knock-in of large reporter genes in human cells via CRISPR/Cas9-induced homology-dependent and independent DNA repair. Nucleic Acids Res. 44, e85 (2016).
  Article PubMed PubMed Central CAS Google Scholar
• Lombardo, A. et al. Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery. Nat. Biotechnol. 25, 1298–1306 (2007).
  Article PubMed CAS Google Scholar
• Lin, S., Staahl, B. T., Alla, R. K. & Doudna, J. A. Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery. Elife 3, e04766 (2014).
  Article PubMed PubMed Central Google Scholar
• Zwaka, T. P. & Thomson, J. A. Homologous recombination in human embryonic stem cells. Nat. Biotechnol. 21, 319–321 (2003).
  Article PubMed CAS Google Scholar
• Hockemeyer, D. et al. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat. Biotechnol. 27, 851–857 (2009).
  Article PubMed PubMed Central CAS Google Scholar
• Liu, Y. & Rao, M. Gene targeting in human pluripotent stem cells. Methods Mol. Biol. 767, 355–367 (2011).
  Article PubMed CAS Google Scholar
• Hockemeyer, D. & Jaenisch, R. Induced pluripotent stem cells meet genome editing. Cell Stem Cell 18, 573–586 (2016).
  Article PubMed PubMed Central CAS Google Scholar
• Song, H., Chung, S. K. & Xu, Y. Modeling disease in human ESCs using an efficient BAC-based homologous recombination system. Cell Stem Cell 6, 80–89 (2010).
  Article PubMed CAS Google Scholar
• Merkle, F. T. et al. Efficient CRISPR-Cas9-mediated generation of knockin human pluripotent stem cells lacking undesired mutations at the targeted locus. Cell Rep. 11, 875–883 (2015).
  Article PubMed PubMed Central CAS Google Scholar
• Merkle, F. T. et al. Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations. Nature 545, 229–233 (2017).
• Avior, Y., Sagi, I. & Benvenisty, N. Pluripotent stem cells in disease modelling and drug discovery. Nat. Rev. Mol. Cell Biol. 17, 170–182 (2016).
  Article PubMed CAS Google Scholar
• González, F. et al. An iCRISPR platform for rapid, multiplexable, and inducible genome editing in human pluripotent stem cells. Cell Stem Cell 15, 215–226 (2014).
  Article PubMed PubMed Central CAS Google Scholar
• Wells, M. F. et al. Genetic ablation of AXL does not protect human neural progenitor cells and cerebral organoids from Zika virus infection. Stem Cell 19, 703–708 (2016).
  CAS Google Scholar
• Liang, X. et al. Rapid and highly efficient mammalian cell engineering via Cas9 protein transfection. J. Biotechnol. 208, 44–53 (2015).
  Article PubMed CAS Google Scholar
• Slaymaker, I. M. et al. Rationally engineered Cas9 nucleases with improved specificity. Science 351, 84–88 (2015).
  Article PubMed PubMed Central CAS Google Scholar
• Banaszynski, L. A., Chen, L., Maynard-Smith, L. A., Ooi, A. G. L. & Wandless, T. J. A. Rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules. Cell 126, 995–1004 (2006).
  Article PubMed PubMed Central CAS Google Scholar
• Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
  Article PubMed PubMed Central CAS Google Scholar
• Chindelevitch, L. et al. Causal reasoning on biological networks: interpreting transcriptional changes. Bioinformatics 28, 1114–1121 (2012).
  Article PubMed CAS Google Scholar
• Jaeger, S. et al. Causal network models for predicting compound targets and driving pathways in cancer. J. Biomol. Screen. 19, 791–802 (2014).
  Article PubMed CAS Google Scholar
• Lane, D. P. p53, Guardian of the genome. Nature 358, 15–16 (1992).
  Article PubMed CAS Google Scholar
• El-Deiry, W. S. et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817–825 (1993).
  Article PubMed CAS Google Scholar
• Canman, C. E. et al. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281, 1677–1679 (1998).
  Article PubMed CAS Google Scholar
• Vassilev, L. T. et al. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303, 844–848 (2004).
  Article PubMed CAS Google Scholar
• Cazzalini, O., Scovassi, A. I., Savio, M., Stivala, L. A. & Prosperi, E. Multiple roles of the cell cycle inhibitor p21(CDKN1A) in the DNA damage response. Mutat. Res. 704, 12–20 (2010).
  Article PubMed CAS Google Scholar
• Schlaeger, T. M. et al. A comparison of non-integrating reprogramming methods. Nat. Biotechnol. 33, 58–63 (2015).
  Article PubMed CAS Google Scholar
• Hong, H. et al. Suppression of induced pluripotent stem cell generation by the p53–p21 pathway. Nature 460, 1132–1135 (2009).
  Article PubMed PubMed Central CAS Google Scholar
• Hagiyama, H. et al. Signaling through the antigen receptor of B lymphocytes activates a p53-independent pathway of c-Myc-induced apoptosis. Oncogene 18, 4091–4098 (1999).
  Article PubMed CAS Google Scholar
• Wang, T. et al. Identification and characterization of essential genes in the human genome. Science 350, 1096–1101 (2015).
  Article PubMed PubMed Central CAS Google Scholar
• Munoz, D. M. et al. CRISPR screens provide a comprehensive assessment of cancer vulnerabilities but generate false-positive hits for highly amplified genomic regions. Cancer Discov. 6, 900–913 (2016).
• Aguirre, A. J. et al. Genomic copy number dictates a gene-independent cell response to CRISPR-Cas9 targeting. Cancer Discov. 2641, 617–632 (2016).
  Google Scholar
• Hart, T. et al. High-resolution CRISPR screens reveal fitness genes and genotype-specific cancer liabilities. Cell 163, 1515–1526 (2015).
• Dumitru, R. et al. Human embryonic stem cells have constitutively active Bax at the golgi and are primed to undergo rapid apoptosis. Mol. Cell 46, 573–583 (2012).
  Article PubMed PubMed Central CAS Google Scholar
• Liu, J. C. et al. High mitochondrial priming sensitizes hESCs to DNA-damage-induced apoptosis. Cell Stem Cell 13, 483–491 (2013).
  Article PubMed PubMed Central CAS Google Scholar
• Hanel, W. & Moll, U. M. Links between mutant p53 and genomic instability. J. Cell. Biochem. 113, 433–439 (2012).
  Article PubMed PubMed Central CAS Google Scholar
• Qin, H. et al. Regulation of apoptosis and differentiation by p53 in human embryonic stem cells. J. Biol. Chem. 282, 5842–5852 (2007).
  Article PubMed CAS Google Scholar
• Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
  Article PubMed PubMed Central CAS Google Scholar
• Sun, Y. et al. A deleterious Nav1.1 mutation selectively impairs telencephalic inhibitory neurons derived from Dravet syndrome patients. eLife 5, e13073 (2016).
  Article PubMed PubMed Central Google Scholar
• Wells, M. F. et al. Genetic ablation of AXL does not protect human neural progenitor cells and cerebral organoids from Zika virus infection. Stem Cell 19, 703–708 (2016).
  CAS Google Scholar
• Bidinosti, M. et al. CLK2 inhibition ameliorates autistic features associated with SHANK3 deficiency. Science 351, 1199–1203 (2016).
  Article PubMed CAS Google Scholar
• Dejesus, R. et al. Functional CRISPR screening identifies the ufmylation pathway as a regulator of SQSTM1/p62. eLife 5, e17290 (2016).
  Article PubMed PubMed Central Google Scholar
• Liang, X. et al. Rapid and highly efficient mammalian cell engineering via Cas9 protein transfection. J. Biotechnol. 208, 44–53 (2015).
  Article PubMed CAS Google Scholar
• Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
  Article PubMed CAS Google Scholar
• Anders, S., Pyl, P. T. & Huber, W. HTSeq—a Python framework to work with high-throughput sequencing data HTSeq. Bioinformatics 31, 166–169 (2015).
  Article PubMed CAS Google Scholar
• Li, B. & Dewey, C. N. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics 12, 323 (2011).
  Article PubMed PubMed Central CAS Google Scholar
• Pfaffl, M. W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, 16–21 (2001).
  Article Google Scholar
• Chindelevitch, L. et al. Causal reasoning on biological networks: interpreting transcriptional changes. Bioinformatics 28, 1114–1121 (2012).
  Article PubMed CAS Google Scholar
• Jaeger, S. et al. Causal network models for predicting compound targets and driving pathways in cancer. J. Biomol. Screen. 19, 791–802 (2014).
  Article PubMed CAS Google Scholar
• Szklarczyk, D. et al. STRINGv10: protein–protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 43, D447–D452 (2015).
  Article PubMed CAS Google Scholar
• Ran, F. A. et al. Double nicking by RNA-guided CRISPR cas9 for enhanced genome editing specificity. Cell 154, 1380–1389 (2013).
  Article PubMed PubMed Central CAS Google Scholar